Clinical Trial Update: Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating radiofrequency ablation for unresectable primary or metastatic liver cancer was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Liver Cancer, Metastatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-06-12